FEM 2023
DOI: 10.57125/fem.2023.03.30.01
|View full text |Cite
|
Sign up to set email alerts
|

An overview of artificial intelligence use in diabetic retinopathy treatment: a narrative review

Abstract: Background: Artificial intelligence (AI), usually called machine intelligence, is a scientific field that allows robots thinking like people. The most common diseases that cause visual impairment and blindness, such as age-related macular degeneration (ARMD), cataract, glaucoma, and diabetic retinopathy (DR), have recently been subject to deep learning-based on AI screening and prediction models. Aim: to discuss the core ideas of AI and its apply to DR, as well as to evaluate the currently faced issues and th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 48 publications
0
0
0
Order By: Relevance